Tu CW - Search Results

1

Sole adjuvant intraoperative breast radiotherapy in Taiwan: a single-center experience.

Yang HY, Tu CW, Chen CC, Lee CY, Hsu YC. Yang HY, et al. Among authors: tu cw. Breast Cancer Res. 2021 Apr 1;23(1):43. doi: 10.1186/s13058-021-01421-y. Breast Cancer Res. 2021. PMID: 33794958 Free PMC article.

2

PCDHB15 as a potential tumor suppressor and epigenetic biomarker for breast cancer.

Chiang CC, Lin GL, Yang SY, Tu CW, Huang WL, Wei CF, Wang FC, Lin PJ, Huang WH, Chuang YM, Lee YT, Yeh CC, Chan MWY, Hsu YC. Chiang CC, et al. Among authors: tu cw. Oncol Lett. 2022 Apr;23(4):117. doi: 10.3892/ol.2022.13237. Epub 2022 Feb 9. Oncol Lett. 2022. PMID: 35261631 Free PMC article.

3

Multi-center study on patient selection for and the oncologic safety of intraoperative radiotherapy (IORT) with the Xoft Axxent® eBx® System for the management of early stage breast cancer in Taiwan.

Lai HW, Liu LC, Ouyang F, Yao CC, Jan HC, Chang YH, Tu CW, Chen DR, Cheng TF, Tzeng YD, Hsu HM, Yeh MH, Wu YC, Yang PS, Lam HB, Hou MF, Chen FM. Lai HW, et al. Among authors: tu cw. PLoS One. 2017 Nov 2;12(11):e0185876. doi: 10.1371/journal.pone.0185876. eCollection 2017. PLoS One. 2017. PMID: 29095832 Free PMC article.

4

Pegylated Liposomal Doxorubicin as Adjuvant Therapy for Stage I-III Operable Breast Cancer.

Lu YC, Ou-Yang FU, Hsieh CM, Chang KJ, Chen DR, Tu CW, Wang HC, Hou MF. Lu YC, et al. Among authors: tu cw. In Vivo. 2016 Mar-Apr;30(2):159-63. In Vivo. 2016. PMID: 26912829

5

Efficacy and toxicity of pegylated liposomal doxorubicin-based chemotherapy in early-stage breast cancer: a multicenter retrospective case-control study.

Yang FO, Hsu NC, Moi SH, Lu YC, Hsieh CM, Chang KJ, Chen DR, Tu CW, Wang HC, Hou MF. Yang FO, et al. Among authors: tu cw. Asia Pac J Clin Oncol. 2018 Jun;14(3):198-203. doi: 10.1111/ajco.12771. Epub 2017 Oct 18. Asia Pac J Clin Oncol. 2018. PMID: 29045014

6

Young-aged woman with invasive ductal carcinoma arising in atypical microglandular adenosis: a case report.

Lee YH, Dai YC, Lin IL, Tu CW. Lee YH, et al. Among authors: tu cw. Pathol Int. 2010 Oct;60(10):685-9. doi: 10.1111/j.1440-1827.2010.02577.x. Pathol Int. 2010. PMID: 20846267

7

Quantitation of Nitration, Chlorination, and Oxidation in Hemoglobin of Breast Cancer Patients by Nanoflow Liquid Chromatography Tandem Mass Spectrometry.

Chen HC, Liao KC, Tu CW. Chen HC, et al. Among authors: tu cw. Chem Res Toxicol. 2021 Jun 21;34(6):1664-1671. doi: 10.1021/acs.chemrestox.1c00075. Epub 2021 Apr 28. Chem Res Toxicol. 2021. PMID: 33909420

8

Operation time is a major risk factor on postoperative nausea and vomiting in women undergoing breast and thyroid surgery.

Lee MY, Wang JD, Tu CW, Alex Tseng CC. Lee MY, et al. Among authors: tu cw. Asian J Surg. 2021 Mar;44(3):590-591. doi: 10.1016/j.asjsur.2020.12.025. Epub 2021 Feb 4. Asian J Surg. 2021. PMID: 33549405 Free article. No abstract available.

9

Integrated Molecular Characterization to Reveal the Association between Kynurenine 3-Monooxygenase Expression and Tumorigenesis in Human Breast Cancers.

Tsang YW, Liao CH, Ke CH, Tu CW, Lin CS. Tsang YW, et al. Among authors: tu cw. J Pers Med. 2021 Sep 24;11(10):948. doi: 10.3390/jpm11100948. J Pers Med. 2021. PMID: 34683090 Free PMC article.

10

Hinokitiol inhibits vasculogenic mimicry activity of breast cancer stem/progenitor cells through proteasome-mediated degradation of epidermal growth factor receptor.

Tu DG, Yu Y, Lee CH, Kuo YL, Lu YC, Tu CW, Chang WW. Tu DG, et al. Among authors: tu cw. Oncol Lett. 2016 Apr;11(4):2934-2940. doi: 10.3892/ol.2016.4300. Epub 2016 Mar 2. Oncol Lett. 2016. PMID: 27073579 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

117 results

Search Page